Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate

Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring rights in the latter’s Brimonidine Tartrate Ophthalmic ... Read More